Latest Insider Transactions at Cvs Health Corp (CVS)
This section provides a real-time view of insider transactions for Cvs Health Corp (CVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CVS HEALTH Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CVS HEALTH Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2017
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,655
-12.1%
|
$363,090
$78.5 P/Share
|
|
Apr 02
2017
|
Helena Foulkes EVP & President-CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,394
-5.05%
|
$186,732
$78.5 P/Share
|
|
Apr 02
2017
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
19,944
-5.98%
|
$1,555,632
$78.5 P/Share
|
|
Apr 02
2017
|
David M Denton EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,649
-3.88%
|
$518,622
$78.5 P/Share
|
|
Apr 02
2017
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,990
-4.92%
|
$311,220
$78.5 P/Share
|
|
Apr 02
2017
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,862
-3.97%
|
$145,236
$78.5 P/Share
|
|
Apr 02
2017
|
Andrew Sussman EVP, Clinical Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,596
-12.04%
|
$124,488
$78.5 P/Share
|
|
Apr 02
2017
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,862
-2.5%
|
$145,236
$78.5 P/Share
|
|
Apr 01
2017
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
12,906
-3.73%
|
$1,006,668
$78.5 P/Share
|
|
Apr 01
2017
|
Thomas M Moriarty EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,617
-8.3%
|
$204,126
$78.5 P/Share
|
|
Apr 01
2017
|
David M Denton EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,420
-1.39%
|
$188,760
$78.5 P/Share
|
|
Apr 01
2017
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,097
-2.52%
|
$163,566
$78.5 P/Share
|
|
Apr 01
2017
|
Stephen J Gold EVP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,396
-4.56%
|
$108,888
$78.5 P/Share
|
|
Apr 01
2017
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,291
-2.68%
|
$100,698
$78.5 P/Share
|
|
Apr 01
2017
|
Andrew Sussman EVP, Clinical Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-7.85%
|
$88,062
$78.5 P/Share
|
|
Apr 01
2017
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,705
-6.56%
|
$210,990
$78.5 P/Share
|
|
Apr 01
2017
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
847
-1.12%
|
$66,066
$78.5 P/Share
|
|
Mar 21
2017
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
23,849
-13.46%
|
$1,860,222
$78.73 P/Share
|
|
Mar 21
2017
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,637
+15.0%
|
$748,665
$45.07 P/Share
|
|
Mar 17
2017
|
Eva C Boratto EVP & CFO |
SELL
Open market or private sale
|
Direct |
6,029
-14.49%
|
$476,291
$79.6 P/Share
|
|
Mar 17
2017
|
Eva C Boratto EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,029
+12.65%
|
$204,986
$34.96 P/Share
|
|
Mar 13
2017
|
Andrew Sussman EVP, Clinical Services |
SELL
Open market or private sale
|
Direct |
14,104
-37.66%
|
$1,128,320
$80.4 P/Share
|
|
Mar 13
2017
|
Andrew Sussman EVP, Clinical Services |
BUY
Exercise of conversion of derivative security
|
Direct |
6,655
+22.59%
|
$299,475
$45.07 P/Share
|
|
Mar 10
2017
|
David M Denton EVP and CFO |
SELL
Open market or private sale
|
Direct |
95,618
-38.2%
|
$7,649,440
$80.68 P/Share
|
|
Mar 10
2017
|
David M Denton EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
95,618
+27.64%
|
$3,442,248
$36.23 P/Share
|
|
Feb 28
2017
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
32,722
-10.54%
|
$2,617,760
$80.58 P/Share
|
|
Feb 28
2017
|
Larry J Merlo Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,255
+18.02%
|
$5,460,400
$80.58 P/Share
|
|
Feb 28
2017
|
Jonathan C Roberts EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,717
+13.82%
|
$1,737,360
$80.58 P/Share
|
|
Feb 28
2017
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,304
-7.36%
|
$264,320
$80.58 P/Share
|
|
Feb 28
2017
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,928
+18.11%
|
$794,240
$80.58 P/Share
|
|
Feb 28
2017
|
Helena Foulkes EVP & President-CVS Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct |
15,512
+23.19%
|
$1,240,960
$80.58 P/Share
|
|
Feb 28
2017
|
Thomas M Moriarty EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
15,512
+40.79%
|
$1,240,960
$80.58 P/Share
|
|
Feb 28
2017
|
Andrew Sussman EVP, Clinical Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,912
-10.59%
|
$152,960
$80.58 P/Share
|
|
Feb 28
2017
|
Andrew Sussman EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct |
1,861
+15.5%
|
$148,880
$80.58 P/Share
|
|
Feb 28
2017
|
Andrew Sussman EVP, Clinical Services |
BUY
Grant, award, or other acquisition
|
Direct |
5,585
+23.62%
|
$446,800
$80.58 P/Share
|
|
Feb 28
2017
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
983
-1.36%
|
$78,640
$80.58 P/Share
|
|
Feb 28
2017
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,482
+6.38%
|
$198,560
$80.58 P/Share
|
|
Feb 28
2017
|
Eva C Boratto EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,385
+7.6%
|
$110,800
$80.58 P/Share
|
|
Feb 28
2017
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,132
-7.32%
|
$490,560
$80.58 P/Share
|
|
Feb 28
2017
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,133
+16.14%
|
$1,290,640
$80.58 P/Share
|
|
Feb 28
2017
|
Robert O. Kraft EVP and President - Omnicare |
SELL
Payment of exercise price or tax liability
|
Direct |
1,256
-11.19%
|
$100,480
$80.58 P/Share
|
|
Feb 28
2017
|
Robert O. Kraft EVP and President - Omnicare |
BUY
Grant, award, or other acquisition
|
Direct |
3,809
+25.34%
|
$304,720
$80.58 P/Share
|
|
Feb 28
2017
|
David M Denton EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,506
-4.63%
|
$600,480
$80.58 P/Share
|
|
Feb 28
2017
|
David M Denton EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
18,615
+10.29%
|
$1,489,200
$80.58 P/Share
|
|
Feb 28
2017
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,705
-2.42%
|
$136,400
$80.58 P/Share
|
|
Feb 28
2017
|
J. David Joyner President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,205
+8.08%
|
$496,400
$80.58 P/Share
|
|
Feb 28
2017
|
Stephen J Gold EVP & CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,462
-11.04%
|
$276,960
$80.58 P/Share
|
|
Feb 28
2017
|
Stephen J Gold EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
9,307
+22.89%
|
$744,560
$80.58 P/Share
|
|
Feb 27
2017
|
Robert O. Kraft EVP and President - Omnicare |
SELL
Payment of exercise price or tax liability
|
Direct |
422
-5.39%
|
$34,182
$81.41 P/Share
|
|
Feb 27
2017
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
189
-0.56%
|
$15,309
$81.41 P/Share
|